{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:16:20Z","timestamp":1791562580108,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fasa university of medical sciences, Fasa, Iran","award":["IR.FUMS.REC.1402.050"],"award-info":[{"award-number":["IR.FUMS.REC.1402.050"]}]},{"name":"Fasa university of medical sciences, Fasa, Iran","award":["IR.FUMS.REC.1402.050"],"award-info":[{"award-number":["IR.FUMS.REC.1402.050"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lung cancer remains a major global health challenge, in part because the efficacy of current treatment modalities is reduced by drug resistance and substantial adverse effects. This study assessed the suitability of liposomes as a drug delivery system to enhance the therapeutic efficacy of docetaxel (DTX) and all-trans retinoic acid (ATRA) against lung cancer. DTX- and ATRA-encapsulated liposomes were synthesized and characterized, exhibiting desirable physicochemical properties such as an appropriate particle size, a negative surface charge, and high drug encapsulation efficiency. in vitro assays using A549 lung cancer cells demonstrated that these liposomes produced markedly greater cytotoxicity compared to free drugs; additionally, these two medications acted synergistically to enhance antitumor activity. Treatment with the liposomes resulted in upregulation of the pro-apoptotic gene Bax and downregulation of the anti-apoptotic gene Bcl-2, indicating activation of apoptotic pathways. Furthermore, the liposomes inhibited cancer cell migration and invasion in vitro, suggesting that they could suppress tumor metastasis. Collectively, these findings provide evidence that liposomes containing DTX and ATRA possess favorable properties for the treatment of lung cancer and may overcome existing challenges to improve patient treatment outcomes. However, comprehensive in vivo studies are required to validate the efficacy and clinical potential of these nanocarriers.<\/jats:p>","DOI":"10.1038\/s41598-025-26078-x","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T11:56:59Z","timestamp":1762516619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preparation of liposomal nanocarriers containing all-trans retinoic acid and docetaxel and their evaluation in a lung cancer cell line"],"prefix":"10.1038","volume":"15","author":[{"given":"Abolfazl","family":"Sinaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Osanloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Zarenezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiva","family":"Alipanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6423-4680","authenticated-orcid":false,"given":"Ali","family":"Ghanbariasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"10","key":"26078_CR1","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.biopha.2007.10.006","volume":"61","author":"P Irigaray","year":"2007","unstructured":"Irigaray, P. et al. Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed. Pharmacother. 61 (10), 640\u2013658 (2007).","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"26078_CR2","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","volume":"13","author":"F Bray","year":"2012","unstructured":"Bray, F., Jemal, A., Grey, N., Ferlay, J. & Forman, D. Global cancer transitions according to the human development index (2008\u20132030): a population-based study. Lancet Oncol. 13 (8), 790\u2013801 (2012).","journal-title":"Lancet Oncol."},{"key":"26078_CR3","unstructured":"Ferlay, J. et al. Global Cancer Observatory: Cancer Today Vol. 20182020 (International agency for research on cancer, 2020)."},{"issue":"6","key":"26078_CR4","doi-asserted-by":"publisher","first-page":"e001021","DOI":"10.1136\/esmoopen-2020-001021","volume":"5","author":"A Ruano-Ravina","year":"2020","unstructured":"Ruano-Ravina, A. et al. Lung cancer symptoms at diagnosis: results of a nationwide registry study. ESMO open. 5 (6), e001021 (2020).","journal-title":"ESMO open."},{"key":"26078_CR5","doi-asserted-by":"crossref","unstructured":"Hardavella, G. et al. Stage I and II nonsmall cell lung cancer treatment options. Breathe 20, (2) (2024).","DOI":"10.1183\/20734735.0219-2023"},{"issue":"3","key":"26078_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/cancers13030400","volume":"13","author":"A Razak","year":"2021","unstructured":"Razak, A. et al. Advances in nanocarriers for effective delivery of docetaxel in the treatment of lung cancer: an overview. Cancers 13 (3), 400 (2021).","journal-title":"Cancers"},{"key":"26078_CR7","doi-asserted-by":"crossref","unstructured":"Siddikuzzaman. & Grace, V. B. Anti-metastatic study of liposome-encapsulated all trans retinoic acid (ATRA) in B16F10 melanoma cells-implanted C57BL\/6 mice. Cancer Invest. 32 (10), 507\u2013517 (2014).","DOI":"10.3109\/07357907.2014.964408"},{"issue":"sup1","key":"26078_CR8","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1080\/10408398.2018.1509201","volume":"59","author":"X Ni","year":"2019","unstructured":"Ni, X., Hu, G. & Cai, X. The success and the challenge of all-trans retinoic acid in the treatment of cancer. Crit. Rev. Food Sci. Nutr. 59 (sup1), S71\u2013S80 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"26078_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jcp.22417","volume":"226","author":"LJ Gudas","year":"2011","unstructured":"Gudas, L. J. & Wagner, J. A. Retinoids regulate stem cell differentiation. J. Cell. Physiol. 226 (2), 322\u2013330 (2011).","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"26078_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s11671-020-3293-3","volume":"15","author":"C Li","year":"2020","unstructured":"Li, C. & Han, X. Co-delivery of Dacarbazine and all-trans retinoic acid (ATRA) using lipid nanoformulations for synergistic antitumor efficacy against malignant melanoma. Nanoscale Res. Lett. 15 (1), 113 (2020).","journal-title":"Nanoscale Res. Lett."},{"key":"26078_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11481-006-9032-4","volume":"1","author":"JD Kingsley","year":"2006","unstructured":"Kingsley, J. D. et al. Nanotechnology: a focus on nanoparticles as a drug delivery system. J. Neuroimmune Pharmacol. 1, 340\u2013350 (2006).","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"8","key":"26078_CR12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2217\/nnm.12.87","volume":"7","author":"S Bamrungsap","year":"2012","unstructured":"Bamrungsap, S. et al. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine 7 (8), 1253\u20131271 (2012).","journal-title":"Nanomedicine"},{"key":"26078_CR13","first-page":"231","volume":"3","author":"V Weissig","year":"1992","unstructured":"Weissig, V. & Gregoriadis, G. Coupling of aminogroup-bearing ligands to liposomes. Liposome Technol. 3, 231\u2013248 (1992).","journal-title":"Liposome Technol."},{"issue":"6","key":"26078_CR14","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/life14060672","volume":"14","author":"MS Gatto","year":"2024","unstructured":"Gatto, M. S., Johnson, M. P. & Najahi-Missaoui, W. Targeted liposomal drug delivery: overview of the current applications and challenges. Life 14 (6), 672 (2024).","journal-title":"Life"},{"issue":"23","key":"26078_CR15","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari, R. B. et al. Combination therapy in combating cancer. Oncotarget 8 (23), 38022 (2017).","journal-title":"Oncotarget"},{"issue":"2","key":"26078_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2012.04.038","volume":"164","author":"H Maeda","year":"2012","unstructured":"Maeda, H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J. Controlled Release. 164 (2), 138\u2013144 (2012).","journal-title":"J. Controlled Release"},{"issue":"4","key":"26078_CR17","first-page":"735","volume":"2","author":"J Suh","year":"2007","unstructured":"Suh, J. et al. PEGylation of nanoparticles improves their cytoplasmic transport. Int. J. Nanomed. 2 (4), 735\u2013741 (2007).","journal-title":"Int. J. Nanomed."},{"key":"26078_CR18","unstructured":"Kataria, S., Sandhu, P., Bilandi, A., Akanksha, M. & Kapoor, B. Stealth liposomes: a review. Int. J. Res. Ayurveda Pharm. 2, (5) (2011)."},{"issue":"11","key":"26078_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","volume":"12","author":"S Mura","year":"2013","unstructured":"Mura, S., Nicolas, J. & Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12 (11), 991\u20131003 (2013).","journal-title":"Nat. Mater."},{"issue":"14","key":"26078_CR20","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1016\/j.biomaterials.2013.01.084","volume":"34","author":"R Cheng","year":"2013","unstructured":"Cheng, R., Meng, F., Deng, C., Klok, H-A. & Zhong, Z. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34 (14), 3647\u20133657 (2013).","journal-title":"Biomaterials"},{"issue":"3","key":"26078_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1039\/C0SM00534G","volume":"7","author":"K Loomis","year":"2011","unstructured":"Loomis, K., McNeeley, K. & Bellamkonda, R. V. Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications. Soft Matter. 7 (3), 839\u2013856 (2011).","journal-title":"Soft Matter"},{"issue":"4","key":"26078_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.34172\/apb.2023.077","volume":"13","author":"A Mahoutforoush","year":"2023","unstructured":"Mahoutforoush, A. et al. Targeted delivery of Pennyroyal via methotrexate functionalized pegylated nanostructured lipid carriers into breast cancer cells; a multiple pathways apoptosis activator. Adv. Pharm. Bull. 13 (4), 747 (2023).","journal-title":"Adv. Pharm. Bull."},{"key":"26078_CR23","doi-asserted-by":"publisher","first-page":"122027","DOI":"10.1016\/j.ijpharm.2022.122027","volume":"624","author":"L Asadollahi","year":"2022","unstructured":"Asadollahi, L. et al. Co-Delivery of erlotinib and Resveratrol via nanostructured lipid carriers: a synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation. Int. J. Pharm. 624, 122027 (2022).","journal-title":"Int. J. Pharm."},{"key":"26078_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-27-37","volume":"27","author":"Y Kucukzeybek","year":"2008","unstructured":"Kucukzeybek, Y. et al. Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone-and drug resistant prostate cancer cell line, DU-145. J. Experimental Clin. Cancer Res. 27, 1\u20138 (2008).","journal-title":"J. Experimental Clin. Cancer Res."},{"key":"26078_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jddst.2017.04.005","volume":"39","author":"VB Grace","year":"2017","unstructured":"Grace, V. B. & Viswanathan, S. Pharmacokinetics and therapeutic efficiency of a novel cationic liposome nano-formulated all trans retinoic acid in lung cancer mice model. J. Drug Deliv. Sci. Technol. 39, 223\u2013236 (2017).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"26078_CR26","doi-asserted-by":"publisher","first-page":"120711","DOI":"10.1016\/j.ijpharm.2021.120711","volume":"604","author":"L Gkionis","year":"2021","unstructured":"Gkionis, L., Aojula, H., Harris, L. K. & Tirella, A. Microfluidic-assisted fabrication of phosphatidylcholine-based liposomes for controlled drug delivery of chemotherapeutics. Int. J. Pharm. 604, 120711 (2021).","journal-title":"Int. J. Pharm."},{"issue":"6","key":"26078_CR27","doi-asserted-by":"publisher","first-page":"pdbprot095505","DOI":"10.1101\/pdb.prot095505","volume":"2018","author":"P Kumar","year":"2018","unstructured":"Kumar, P., Nagarajan, A. & Uchil, P. Analysis of cell viability by the MTT assay. Cold Spring Harbor Protoc. 2018 (6), pdbprot095505 (2018).","journal-title":"Cold Spring Harbor Protoc."},{"issue":"2","key":"26078_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.watres.2009.07.026","volume":"44","author":"I Rodea-Palomares","year":"2010","unstructured":"Rodea-Palomares, I. et al. Application of the combination index (CI)-isobologram equation to study the toxicological interactions of lipid regulators in two aquatic bioluminescent organisms. Water Res. 44 (2), 427\u2013438 (2010).","journal-title":"Water Res."},{"key":"26078_CR29","doi-asserted-by":"crossref","unstructured":"Rio, D. C., Ares, M., Hannon, G. J. & Nilsen, T. W. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harbor Protocols. 2010 (6), pdb.prot5439. (2010).","DOI":"10.1101\/pdb.prot5439"},{"key":"26078_CR30","doi-asserted-by":"crossref","unstructured":"Fraga, D., Meulia, T. & Fenster, S. Real-time PCR. Current protocols essential laboratory techniques. 8 (1), 10.3. 1-.3. 40. (2014).","DOI":"10.1002\/9780470089941.et1003s08"},{"issue":"151","key":"26078_CR31","doi-asserted-by":"publisher","first-page":"20180709","DOI":"10.1098\/rsif.2018.0709","volume":"16","author":"AVP Bobadilla","year":"2019","unstructured":"Bobadilla, A. V. P. et al. In vitro cell migration quantification method for scratch assays. J. Royal Soc. Interface. 16 (151), 20180709 (2019).","journal-title":"J. Royal Soc. Interface"},{"key":"26078_CR32","doi-asserted-by":"crossref","unstructured":"Gupta, P., Mazumder, R. & Padhi, S. Glycerosomes: advanced liposomal drug delivery system. Indian J. Pharm. Sci. 82 (3), (2020).","DOI":"10.36468\/pharmaceutical-sciences.661"},{"issue":"6","key":"26078_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jps.1023","volume":"90","author":"T Lian","year":"2001","unstructured":"Lian, T. & Ho, R. J. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90 (6), 667\u2013680 (2001).","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"26078_CR34","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/polym13071027","volume":"13","author":"V De Leo","year":"2021","unstructured":"De Leo, V., Milano, F., Agostiano, A. & Catucci, L. Recent advancements in polymer\/liposome assembly for drug delivery: from surface modifications to hybrid vesicles. Polymers 13 (7), 1027 (2021).","journal-title":"Polymers"},{"key":"26078_CR35","unstructured":"Pavia, D. L., Lampman, G. M., Kriz, G. S. & Vyvyan, J. R. Introduction to spectroscopy. (2015)."},{"issue":"9","key":"26078_CR36","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.eurpolymj.2013.02.025","volume":"49","author":"Z Varga","year":"2013","unstructured":"Varga, Z., Mih\u00e1ly, J., Ber\u00e9nyi, S. & B\u00f3ta, A. Structural characterization of the Poly (ethylene glycol) layer of sterically stabilized liposomes by means of FTIR spectroscopy. Eur. Polymer J. 49 (9), 2415\u20132421 (2013).","journal-title":"Eur. Polymer J."},{"issue":"6","key":"26078_CR37","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4103\/1735-5362.217427","volume":"12","author":"E Shakiba","year":"2017","unstructured":"Shakiba, E., Khazaei, S., Hajialyani, M., Astinchap, B. & Fattahi, A. Preparation and in vitro characterization of retinoic acid-loaded Poly (\u03b5-caprolactone)-poly (ethylene glycol)-poly (\u03b5-caprolactone) micelles. Res. Pharm. Sci. 12 (6), 465\u2013478 (2017).","journal-title":"Res. Pharm. Sci."},{"issue":"1","key":"26078_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/gels8010055","volume":"8","author":"SSB Rizvi","year":"2022","unstructured":"Rizvi, S. S. B., Akhtar, N., Minhas, M. U., Mahmood, A. & Khan, K. U. Synthesis and characterization of carboxymethyl Chitosan nanosponges with cyclodextrin blends for drug solubility improvement. Gels 8 (1), 55 (2022).","journal-title":"Gels"},{"issue":"17","key":"26078_CR39","first-page":"3752","volume":"55","author":"F Yuan","year":"1995","unstructured":"Yuan, F. et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55 (17), 3752\u20133756 (1995).","journal-title":"Cancer Res."},{"key":"26078_CR40","unstructured":"Larsson, M., Hill, A. & Duffy, J. Suspension stability; why particle size, zeta potential and rheology are important. Annual Trans. Nordic Rheology Soc. 20 (6), (2012)."},{"key":"26078_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejps.2017.05.038","volume":"105","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy. Eur. J. Pharm. Sci. 105, 219\u2013229 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"26078_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1139\/y79-081","volume":"57","author":"D Stamp","year":"1979","unstructured":"Stamp, D. & Juliano, R. Factors affecting the encapsulation of drugs within liposomes. Can. J. Physiol. Pharmacol. 57 (5), 535\u2013539 (1979).","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"3","key":"26078_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0168-3659(03)00271-2","volume":"91","author":"ML Immordino","year":"2003","unstructured":"Immordino, M. L. et al. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J. Controlled Release. 91 (3), 417\u2013429 (2003).","journal-title":"J. Controlled Release"},{"issue":"2","key":"26078_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3797\/scipharm.0806-08","volume":"77","author":"A Yousefi","year":"2009","unstructured":"Yousefi, A., Esmaeili, F., Rahimian, S., Atyabi, F. & Dinarvand, R. Preparation and in vitro evaluation of a pegylated nano-liposomal formulation containing docetaxel. Sci. Pharm. 77 (2), 453\u2013464 (2009).","journal-title":"Sci. Pharm."},{"issue":"1","key":"26078_CR45","first-page":"111","volume":"13","author":"LH Lindner","year":"2010","unstructured":"Lindner, L. H. & Hossann, M. Factors affecting drug release from liposomes. Curr. Opin. Drug Discov. Devel. 13 (1), 111\u2013123 (2010).","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"26078_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2015.01.009","volume":"749","author":"B Li","year":"2015","unstructured":"Li, B. et al. The synergistic antitumor effects of all-trans retinoic acid and C-phycocyanin on the lung cancer A549 cells in vitro and in vivo. Eur. J. Pharmacol. 749, 107\u2013114 (2015).","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"26078_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/abbs\/gmw072","volume":"48","author":"K Wang","year":"2016","unstructured":"Wang, K., Zhu, X., Zhang, K., Zhu, L. & Zhou, F. FoxM1 Inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK\/mitochondrial pathway. Acta Biochim. Biophys. Sin. 48 (9), 804\u2013809 (2016).","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"9","key":"26078_CR48","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2217\/nnm.13.118","volume":"8","author":"PP Deshpande","year":"2013","unstructured":"Deshpande, P. P., Biswas, S. & Torchilin, V. P. Current trends in the use of liposomes for tumor targeting. Nanomedicine 8 (9), 1509\u20131528 (2013).","journal-title":"Nanomedicine"},{"issue":"2","key":"26078_CR49","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1158\/1535-7163.MCT-06-0564","volume":"6","author":"NM Mhaidat","year":"2007","unstructured":"Mhaidat, N. M., Wang, Y., Kiejda, K. A., Zhang, X. D. & Hersey, P. Docetaxel-induced apoptosis in melanoma cells is dependent on activation of caspase-2. Mol. Cancer Ther. 6 (2), 752\u2013761 (2007).","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"26078_CR50","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/bjc.1998.32","volume":"77","author":"R Mangiarotti","year":"1998","unstructured":"Mangiarotti, R., Danova, M., Alberici, R. & Pellicciari, C. All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells. Br. J. Cancer. 77 (2), 186\u2013191 (1998).","journal-title":"Br. J. Cancer"},{"issue":"10","key":"26078_CR51","doi-asserted-by":"publisher","first-page":"17216","DOI":"10.18632\/oncotarget.15303","volume":"8","author":"SK Singh","year":"2017","unstructured":"Singh, S. K., Banerjee, S., Acosta, E. P., Lillard, J. W. & Singh, R. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53\/p21WAF1\/CIP1 and p27KIP1 pathway. Oncotarget 8 (10), 17216 (2017).","journal-title":"Oncotarget"},{"issue":"39","key":"26078_CR52","doi-asserted-by":"publisher","first-page":"21735","DOI":"10.1039\/C8RA02833H","volume":"8","author":"J Tao","year":"2018","unstructured":"Tao, J. et al. Co-delivery of Dihydroartemisinin and docetaxel in pH-sensitive nanoparticles for treating metastatic breast cancer via the NF-\u03baB\/MMP-2 signal pathway. RSC Adv. 8 (39), 21735\u201321744 (2018).","journal-title":"RSC Adv."},{"issue":"3","key":"26078_CR53","first-page":"4220","volume":"8","author":"J Cheng","year":"2015","unstructured":"Cheng, J. et al. ATRA and genistein synergistically inhibit the metastatic potential of human lung adenocarcinoma cells. Int. J. Clin. Exp. Med. 8 (3), 4220 (2015).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"26078_CR54","doi-asserted-by":"publisher","first-page":"213043","DOI":"10.1016\/j.bioadv.2022.213043","volume":"140","author":"SM Torcasio","year":"2022","unstructured":"Torcasio, S. M. et al. Three-armed RGD-decorated starPLA-PEG nanoshuttle for docetaxel delivery. Biomaterials Adv. 140, 213043 (2022).","journal-title":"Biomaterials Adv."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26078-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:03:31Z","timestamp":1762520611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26078-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26078"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26078-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39066"}}